Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome) Latest Advances

Endovascular Treatment of Bow Hunter's Syndrome Presenting With Acute Vertebral Artery Occlusion: A Case Report.

Journal: Vascular and endovascular surgery

Published: August 20, 2026

Author Correction: Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome.

Journal: EMBO molecular medicine

Published: July 11, 2026

Research highlights.

Journal: The FEBS journal

Published: June 29, 2026

Dynamic Angiography Demonstrating Discogenic Bow Hunter Syndrome.

Journal: Stroke

Published: June 22, 2026

Gorham-Stout disease of the craniovertebral junction presenting with bow hunter syndrome and cerebellar infarction treated by occipitocervical fusion: illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: June 11, 2026

Intraoperative High-Resolution 2-Dimensional and 3-Dimensional Angiography in Cervical Decompression for Subaxial Bow Hunter's Syndrome.

Journal: World neurosurgery

Published: May 28, 2026

Hunter Syndrome: The Pediatric Surgeon's Point of View.

Journal: The Israel Medical Association journal : IMAJ

Published: May 18, 2026

Interim analysis of post-marketing surveillance study of intracerebroventricular idursulfase therapy for neuronopathic mucopolysaccharidosis type II: Safety and effectiveness in clinical practice in Japan.

Journal: Molecular genetics and metabolism

Published: May 08, 2026

Tividenofusp Alfa: First Approval.

Journal: Molecular diagnosis & therapy

Published: May 07, 2026

Combined Intracerebroventricular Enzyme Replacement and Cord Blood Transplantation in Patients with Mucopolysaccharidosis Type II Diagnosed Through Newborn Screening.

Journal: International journal of neonatal screening

Published: May 07, 2026

Symptomatic Bilateral Vertebral Artery Aneurysms due to C1-2 Hypermobility (Bow Hunter's Syndrome).

Journal: Stroke

Published: April 27, 2026

The Impact of Hydrotherapy on Health-Related Quality of Life, Pain and Mobility in Individuals With Mucopolysaccharidosis Type II (Hunter Syndrome): A Pilot Feasibility Study.

Journal: JIMD reports

Published: April 21, 2026

Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome) Latest Advances

Find the Latest Research About Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)

Endovascular Treatment of Bow Hunter's Syndrome Presenting With Acute Vertebral Artery Occlusion: A Case Report.

Endovascular Treatment of Bow Hunter's Syndrome Presenting With Acute Vertebral Artery Occlusion: A Case Report.

Author Correction: Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome.

Author Correction: Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome.

Research highlights.

Research highlights.

Dynamic Angiography Demonstrating Discogenic Bow Hunter Syndrome.

Dynamic Angiography Demonstrating Discogenic Bow Hunter Syndrome.

Gorham-Stout disease of the craniovertebral junction presenting with bow hunter syndrome and cerebellar infarction treated by occipitocervical fusion: illustrative case.

Gorham-Stout disease of the craniovertebral junction presenting with bow hunter syndrome and cerebellar infarction treated by occipitocervical fusion: illustrative case.

Intraoperative High-Resolution 2-Dimensional and 3-Dimensional Angiography in Cervical Decompression for Subaxial Bow Hunter's Syndrome.

Intraoperative High-Resolution 2-Dimensional and 3-Dimensional Angiography in Cervical Decompression for Subaxial Bow Hunter's Syndrome.

Hunter Syndrome: The Pediatric Surgeon's Point of View.

Hunter Syndrome: The Pediatric Surgeon's Point of View.

Interim analysis of post-marketing surveillance study of intracerebroventricular idursulfase therapy for neuronopathic mucopolysaccharidosis type II: Safety and effectiveness in clinical practice in Japan.

Interim analysis of post-marketing surveillance study of intracerebroventricular idursulfase therapy for neuronopathic mucopolysaccharidosis type II: Safety and effectiveness in clinical practice in Japan.

Tividenofusp Alfa: First Approval.

Tividenofusp Alfa: First Approval.

Combined Intracerebroventricular Enzyme Replacement and Cord Blood Transplantation in Patients with Mucopolysaccharidosis Type II Diagnosed Through Newborn Screening.

Combined Intracerebroventricular Enzyme Replacement and Cord Blood Transplantation in Patients with Mucopolysaccharidosis Type II Diagnosed Through Newborn Screening.

Symptomatic Bilateral Vertebral Artery Aneurysms due to C1-2 Hypermobility (Bow Hunter's Syndrome).

Symptomatic Bilateral Vertebral Artery Aneurysms due to C1-2 Hypermobility (Bow Hunter's Syndrome).

The Impact of Hydrotherapy on Health-Related Quality of Life, Pain and Mobility in Individuals With Mucopolysaccharidosis Type II (Hunter Syndrome): A Pilot Feasibility Study.

The Impact of Hydrotherapy on Health-Related Quality of Life, Pain and Mobility in Individuals With Mucopolysaccharidosis Type II (Hunter Syndrome): A Pilot Feasibility Study.